|
|
||||||||||
Research Articles |
The effect of pregnancy on hepatic drug-metabolizing enzyme activity was investigated in nine healthy pregnant women using the ratio of 6-hydroxycortisol (6-OHF), to total 17-hydroxycorticosteroid (17-OHCS) in 24-hour urine as an index of the hepatic monooxygenase activity. The values of 6-OHF and the ratio (713 +/- 250 micrograms/d and 0.323 +/- 0.242; mean +/- SD) before delivery were significantly higher than they were during early puerperium (395 +/- 145 micrograms/d and 0.114 +/- 0.055) and approximately three months after delivery (237 +/- 67 micrograms/d and 0.066 +/- 0.034). Although the values three months after delivery were comparable to those found in the nonpregnant group (n = 10; 228 +/- 48 micrograms/d and 0.081 +/- 0.031), 6-OHF values one week after delivery were significantly higher than those observed in the control group. These observations suggest that drug-metabolizing enzyme induction may occur during pregnancy.
This article has been cited by other articles:
![]() |
Y. Zhang, M.-J. Kim, J. S. Bertino Jr, A. N. Nafziger, and E. M. Sellers Use of Omeprazole as a CYP3A Probe Drug: Effect of Sex and Menstrual Cycle Phase on CYP3A Activity in Healthy Caucasian Adults. J. Clin. Pharmacol., March 1, 2006; 46(3): 345 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Sturgill and G. H. Lambert Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function Clin. Chem., August 1, 1997; 43(8): 1512 - 1526. [Abstract] [Full Text] [PDF] |
||||